CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 97,412	$ 99,216
Marketable securities	37,565	15,000
Research and development incentive receivable	1,073	562
Inventory	2,445	0
Prepaid expenses and other current assets	4,477	7,298
Total current assets	142,972	122,076
Property and equipment, net	820	745
Goodwill	17,351	17,351
Finite-Lived Intangible Assets, Net	10,188	0
Right-of-use assets	4,471	5,650
Other assets	2,363	1,436
Total assets	178,165	147,258
Current liabilities:
Accounts payable	8,577	8,947
Accrued expenses (Note 9)	19,459	12,816
Current portion of lease liability	1,222	1,099
Total current liabilities	29,258	22,862
Long-term debt, including accretion, net of discount	75,224	54,570
Lease liabilities	1,757	2,612
Warrant liability (Note 5)	11,087	15,683
Other liabilities	1,218	432
Total liabilities	118,544	96,159
Commitments and contingencies (Note 12)
Stockholders’ equity:
Common stock, $0.001 par value, 500,000,000 shares authorized as of September 30, 2024 and December 31, 2023, respectively; 168,511,264 and 167,434,595 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	168	167
Additional paid-in capital	535,101	528,956
Accumulated other comprehensive loss	(114)	(119)
Accumulated deficit	(475,534)	(477,905)
Total stockholders’ equity	59,621	51,099
Total liabilities and stockholders’ equity	$ 178,165	$ 147,258